Alejandro Soto-gutierrez

University of Pittsburgh

NIH Rank #1826
  • Program Leader
  • R01 Holder
  • Top 10% Funded
  • Early Career
  • Diverse Portfolio

NIH Funding · FY2024

Total Funding
$3.7M
Fiscal year 2024
Grants Awarded
6
Active NIH grants
National Rank
#1,826
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $3.7M across 6 grants · National rank #1826.

Top grants by award amount

Alejandro Soto-gutierrez's NIH grant portfolio, ranked by award amount.

  • 1U2CTR004863-01U2C
    Qualification of Patient-Derived Biomimetic Liver MPS as Drug Discovery Tools for Drug Metabolism, Toxicity, Drug Efficacy Testing and Clinical Trial Cohort Selection
    $1.1M
    award amount
  • 5UH3TR003289-05UH3
    A vascularized patient-derived iPSC liver acinus microphysiology system as an innovative precision medicine platform for optimizing clinical trial design for nonalcoholic fatty liver disease
    $777.5K
    award amount
  • 1R01DK135606-01A1R01
    Implementing A QSP Platform to Predict and Test Drugs for Metabolic Associated Fatty Liver Disease Genetic Variants in an iPSC-cell Based Human Biomimetic Liver Microphysiology System
    $695.6K
    award amount
  • 5R01DK099257-08R01
    Mini-Livers Derived from Human IPS Cells for Modeling Steatosis and Therapy
    $506.2K
    award amount
  • 1R24DK139775-01R24
    Human Liver Tissue & Hepatocytes Research Resource (HLTHRR)
    $495.9K
    award amount
  • 2P30DK120531-06P30
    Pittsburgh Liver Research Center
    $90.7K
    award amount

Affiliation

Institutions that have administered grants for Alejandro Soto-gutierrez.

Affiliated with University of Pittsburgh (PA).

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    University of Pittsburgh
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #1826
  6. 2024
    Entered Top 25% Nationally
    Ranked #1826
  7. 2024
    Entered Top 10% Nationally
    Ranked #1826